Effects of 5-Aza-2′-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line

Oncology Letters

Volumn 6, Issue 3, 2013, Pages 845-849

  Yan, Hongchao ^a   Yu, Nan ^a   Tong, Jianye ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

5 Aza 2 deoxycytidine; Ovarian cancer; WWOX gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CARCINOGENIC ACTIVITY; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; OVARY CANCER; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; ULTRAVIOLET SPECTROPHOTOMETRY; WESTERN BLOTTING; WWOX GENE;

EID: 84880407960     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1438     Document Type: Article

References (16)

1. Barton CA, Hacker NF, Clark SJ and O'Brien PM: DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecol Oncol 109: 129-139, 2008.
2. Houshdaran S, Hawley S, Palmer C, et al: DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS One 5: e9359, 2010.
3. Bednarek AK, Laflin KJ, Daniel RL, et al: WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 60: 2140-2145, 2000.
4. Del Mare S, Salah Z and Aqeilan RI: WWOX: its genomics, partners, and functions. J Cell Biochem 108: 737-745, 2009.
5. Lewandowska U, Zelazowski M, Seta K, et al: WWOX, the tumour suppressor gene affected in multiple cancers. J Physiol Pharmacol 60: 47-56, 2009.
6. Wang X, Chao L, Jin G, et al: Association between CpG island methylation of the WWOX gene and its expression in breast cancers. Tumour Biol 30: 8-14, 2009.
7. Dehan P, Kustermans G, Guenin S, et al: DNA methylation and cancer diagnosis: new methods and applications. Expert Rev Mol Diagn 9: 651-657, 2009.
8. Worthley DL, Whitehall VL, Buttenshaw RL, et al: DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 29: 1653-1662, 2010.
9. Kiran M, Chawla YK and Kaur J: Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Cancer Genet Cytogenet 195: 112-119, 2009.
10. Sharma G, Mirza S, Parshad R, et al: CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem 43: 373-379, 2010.
11. Kuroda A, Rauch TA, Todorov I, et al: Insulin gene expression is regulated by DNA methylation. PLoS One 4: e6953, 2009.
12. Lewandowska J and Bartoszek A: DNA methylation in cancer development, diagnosis and therapy-multiple opportunities for genotoxic agents to act as methylome disruptors or remediators. Mutagenesis 26: 475-487, 2011.
13. Gaudet MM, Campan M, Figueroa JD, et al: DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomarkers Prev 18: 3036-3043, 2009.
14. Weng YI, Huang TH and Yan PS: Methylated DNA immunoprecipitation and microarray-based analysis: detection of DNA methylation in breast cancer cell lines. Methods Mol Biol 590: 165-176, 2009.
15. Sceusi EL, Loose DS and Wray CJ: Clinical implications of DNA methylation in hepatocellular carcinoma. HPB (Oxford) 13: 369-376, 2011.
16. Espada J and Esteller M: DNA methylation and the functional organization of the nuclear compartment. Semin Cell Dev Biol 21: 238-246, 2010.